You are here: Industry Insights > COVID-19

News List

Phase III COVID-19 antibody trials initiated in Americas europeanpharmaceuticalreview
July 10, 2020
Simultaneous Phase III trials evaluating Regeneron’s REGN-COV2 antibody as both a prophylactic and a treatment have begun in US and some South American locations.
Russia approves R-Pharm’s Coronavir for Covid-19 treatment pharmaceutical-technology
July 10, 2020
Russian pharmaceutical company R-Pharm has secured regulatory approval for the use of its antiviral drug Coronavir, to treat patients suffering from Covid-19.
Emergent BioSolutions and partners to develop Covid-19 therapy pharmaceutical-technology
July 10, 2020
Emergent BioSolutions has partnered with the Mount Sinai Health System and ImmunoTek Bio Centers for the development, manufacture and clinical testing of its Covid-19 hyperimmune globulin candidate, COVID-HIG.
EU secures potential COVID-19 drugs from Roche, Germany’s Merck – source expresspharma
July 10, 2020
The deals cover Roche’s arthritis drug RoActemra and Merck’s multiple sclerosis drug Rebif - both seen as potential COVID-19 therapies - and will secure supplies for any of the 27 European Union member states wanting to buy them.
Gilead begins testing inhalable form of remdesivir for COVID-19 expresspharma
July 10, 2020
The company said the trial will test the drug particularly in those cases where the disease has not progressed to require hospitalization.
Coronavirus tricks the body into attacking brain; common heartburn drugs linked to coronavirus risk expresspharma
July 10, 2020
Widely used heartburn drugs that have been linked with numerous complications including higher risk for kidney disease and dementia with long-term use may also be tied to a higher risk for COVID-19.
New clinical trial platform launched to accelerate COVID-19 treatments pharmatimes
July 09, 2020
The University of Liverpool, Liverpool School of Tropical Medicine and Southampton Clinical Trials Unit have launched an innovative COVID-19 drug testing platform, AGILE, in the hope of accelerating the development of the most promising therapies.
INOVIO Announces Positive Interim Phase 1 Data for INO-4800 Vaccine for COVID-19 americanpharmaceuticalreview
July 09, 2020
INOVIO announced positive interim clinical data of INO-4800, its vaccine candidate against novel coronavirus (SARS-CoV-2), from the first two Phase 1 clinical trial cohorts.
US awards $450m contract to Regeneron for Covid-19 therapy supply pharmaceutical-technology
July 09, 2020
Regeneron Pharmaceuticals has received a $450m contract from the US Biomedical Advanced Research and Development Authority (BARDA) and the Department of Defense for the manufacture and supply of its antibody cocktail therapy against Covid-19.
Doctors view ‘a(chǎn)ntiviral agents’ as the most effective therapeutic option for treating COVID-19: Course5 Intelligence expresspharma
July 09, 2020
Anti-inflammatory drugs, convalescent plasma therapy are opined to be the next-best treatments; AI, ML, Big Data and IoT emerge as powerful tools.